ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Recombinant Human Parathyroid Hormone - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-13P15302
Home | Market Reports | Science| Biological Sciences
Global Recombinant Human Parathyroid Hormone Market Research Report 2023
BUY CHAPTERS

Recombinant Human Parathyroid Hormone - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-13P15302
Report
September 2024
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Takeda
Ascendis Pharma
Beijing SL Pharmaceutical
NPS Pharma(Shire)
Shandong Buchang Pharmaceuticals

Recombinant Human Parathyroid Hormone - Market Size

The global market for Recombinant Human Parathyroid Hormone was estimated to be worth US$ 144 million in 2023 and is forecast to a readjusted size of US$ 228.5 million by 2030 with a CAGR of 6.8% during the forecast period 2024-2030

Recombinant Human Parathyroid Hormone - Market

Recombinant Human Parathyroid Hormone - Market

Recombinant Human Parathyroid Hormone is an artificially manufactured form of the parathyroid hormone used to treat hypoparathyroidism. Recombinant human parathyroid hormone is used in the treatment of osteoporosis in postmenopausal women at high risk of osteoporotic fractures. A significant reduction in the incidence of vertebral fractures has been demonstrated.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Human Parathyroid Hormone, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Recombinant Human Parathyroid Hormone by region & country, by Type, and by Application.
The Recombinant Human Parathyroid Hormone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Parathyroid Hormone.
Market Segmentation

Scope of Recombinant Human Parathyroid Hormone - Market Report

Report Metric Details
Report Name Recombinant Human Parathyroid Hormone - Market
Forecasted market size in 2030 US$ 228.5 million
CAGR 6.8%
Forecasted years 2024 - 2030
Segment by Type:
  • 25 mcg/dose
  • 50 mcg/dose
  • 75 mcg/dose
  • 100 mcg/dose
Segment by Application
  • Postmenopausal Women with Osteoporosis
  • Hypocalcemia in Patients with Hypoparathyroidism
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company NPS Pharma(Shire), Takeda, Shandong Buchang Pharmaceuticals, Ascendis Pharma, Beijing SL Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Recombinant Human Parathyroid Hormone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Recombinant Human Parathyroid Hormone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Recombinant Human Parathyroid Hormone in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Recombinant Human Parathyroid Hormone - Market size in 2030?

Ans: The Recombinant Human Parathyroid Hormone - Market size in 2030 will be US$ 228.5 million.

Who are the main players in the Recombinant Human Parathyroid Hormone - Market report?

Ans: The main players in the Recombinant Human Parathyroid Hormone - Market are NPS Pharma(Shire), Takeda, Shandong Buchang Pharmaceuticals, Ascendis Pharma, Beijing SL Pharmaceutical

What are the Application segmentation covered in the Recombinant Human Parathyroid Hormone - Market report?

Ans: The Applications covered in the Recombinant Human Parathyroid Hormone - Market report are Postmenopausal Women with Osteoporosis, Hypocalcemia in Patients with Hypoparathyroidism

What are the Type segmentation covered in the Recombinant Human Parathyroid Hormone - Market report?

Ans: The Types covered in the Recombinant Human Parathyroid Hormone - Market report are 25 mcg/dose, 50 mcg/dose, 75 mcg/dose, 100 mcg/dose

1 Market Overview
1.1 Recombinant Human Parathyroid Hormone Product Introduction
1.2 Global Recombinant Human Parathyroid Hormone Market Size Forecast
1.2.1 Global Recombinant Human Parathyroid Hormone Sales Value (2019-2030)
1.2.2 Global Recombinant Human Parathyroid Hormone Sales Volume (2019-2030)
1.2.3 Global Recombinant Human Parathyroid Hormone Sales Price (2019-2030)
1.3 Recombinant Human Parathyroid Hormone Market Trends & Drivers
1.3.1 Recombinant Human Parathyroid Hormone Industry Trends
1.3.2 Recombinant Human Parathyroid Hormone Market Drivers & Opportunity
1.3.3 Recombinant Human Parathyroid Hormone Market Challenges
1.3.4 Recombinant Human Parathyroid Hormone Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Recombinant Human Parathyroid Hormone Players Revenue Ranking (2023)
2.2 Global Recombinant Human Parathyroid Hormone Revenue by Company (2019-2024)
2.3 Global Recombinant Human Parathyroid Hormone Players Sales Volume Ranking (2023)
2.4 Global Recombinant Human Parathyroid Hormone Sales Volume by Company Players (2019-2024)
2.5 Global Recombinant Human Parathyroid Hormone Average Price by Company (2019-2024)
2.6 Key Manufacturers Recombinant Human Parathyroid Hormone Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Recombinant Human Parathyroid Hormone Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Recombinant Human Parathyroid Hormone
2.9 Recombinant Human Parathyroid Hormone Market Competitive Analysis
2.9.1 Recombinant Human Parathyroid Hormone Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Recombinant Human Parathyroid Hormone Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Parathyroid Hormone as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 25 mcg/dose
3.1.2 50 mcg/dose
3.1.3 75 mcg/dose
3.1.4 100 mcg/dose
3.2 Global Recombinant Human Parathyroid Hormone Sales Value by Type
3.2.1 Global Recombinant Human Parathyroid Hormone Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Recombinant Human Parathyroid Hormone Sales Value, by Type (2019-2030)
3.2.3 Global Recombinant Human Parathyroid Hormone Sales Value, by Type (%) (2019-2030)
3.3 Global Recombinant Human Parathyroid Hormone Sales Volume by Type
3.3.1 Global Recombinant Human Parathyroid Hormone Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Recombinant Human Parathyroid Hormone Sales Volume, by Type (2019-2030)
3.3.3 Global Recombinant Human Parathyroid Hormone Sales Volume, by Type (%) (2019-2030)
3.4 Global Recombinant Human Parathyroid Hormone Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Postmenopausal Women with Osteoporosis
4.1.2 Hypocalcemia in Patients with Hypoparathyroidism
4.2 Global Recombinant Human Parathyroid Hormone Sales Value by Application
4.2.1 Global Recombinant Human Parathyroid Hormone Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Recombinant Human Parathyroid Hormone Sales Value, by Application (2019-2030)
4.2.3 Global Recombinant Human Parathyroid Hormone Sales Value, by Application (%) (2019-2030)
4.3 Global Recombinant Human Parathyroid Hormone Sales Volume by Application
4.3.1 Global Recombinant Human Parathyroid Hormone Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Recombinant Human Parathyroid Hormone Sales Volume, by Application (2019-2030)
4.3.3 Global Recombinant Human Parathyroid Hormone Sales Volume, by Application (%) (2019-2030)
4.4 Global Recombinant Human Parathyroid Hormone Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Recombinant Human Parathyroid Hormone Sales Value by Region
5.1.1 Global Recombinant Human Parathyroid Hormone Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Recombinant Human Parathyroid Hormone Sales Value by Region (2019-2024)
5.1.3 Global Recombinant Human Parathyroid Hormone Sales Value by Region (2025-2030)
5.1.4 Global Recombinant Human Parathyroid Hormone Sales Value by Region (%), (2019-2030)
5.2 Global Recombinant Human Parathyroid Hormone Sales Volume by Region
5.2.1 Global Recombinant Human Parathyroid Hormone Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Recombinant Human Parathyroid Hormone Sales Volume by Region (2019-2024)
5.2.3 Global Recombinant Human Parathyroid Hormone Sales Volume by Region (2025-2030)
5.2.4 Global Recombinant Human Parathyroid Hormone Sales Volume by Region (%), (2019-2030)
5.3 Global Recombinant Human Parathyroid Hormone Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Recombinant Human Parathyroid Hormone Sales Value, 2019-2030
5.4.2 North America Recombinant Human Parathyroid Hormone Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Recombinant Human Parathyroid Hormone Sales Value, 2019-2030
5.5.2 Europe Recombinant Human Parathyroid Hormone Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Recombinant Human Parathyroid Hormone Sales Value, 2019-2030
5.6.2 Asia Pacific Recombinant Human Parathyroid Hormone Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Recombinant Human Parathyroid Hormone Sales Value, 2019-2030
5.7.2 South America Recombinant Human Parathyroid Hormone Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Recombinant Human Parathyroid Hormone Sales Value, 2019-2030
5.8.2 Middle East & Africa Recombinant Human Parathyroid Hormone Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Recombinant Human Parathyroid Hormone Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Recombinant Human Parathyroid Hormone Sales Value
6.2.1 Key Countries/Regions Recombinant Human Parathyroid Hormone Sales Value, 2019-2030
6.2.2 Key Countries/Regions Recombinant Human Parathyroid Hormone Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Recombinant Human Parathyroid Hormone Sales Value, 2019-2030
6.3.2 United States Recombinant Human Parathyroid Hormone Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Recombinant Human Parathyroid Hormone Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Recombinant Human Parathyroid Hormone Sales Value, 2019-2030
6.4.2 Europe Recombinant Human Parathyroid Hormone Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Recombinant Human Parathyroid Hormone Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Recombinant Human Parathyroid Hormone Sales Value, 2019-2030
6.5.2 China Recombinant Human Parathyroid Hormone Sales Value by Type (%), 2023 VS 2030
6.5.3 China Recombinant Human Parathyroid Hormone Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Recombinant Human Parathyroid Hormone Sales Value, 2019-2030
6.6.2 Japan Recombinant Human Parathyroid Hormone Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Recombinant Human Parathyroid Hormone Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Recombinant Human Parathyroid Hormone Sales Value, 2019-2030
6.7.2 South Korea Recombinant Human Parathyroid Hormone Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Recombinant Human Parathyroid Hormone Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Recombinant Human Parathyroid Hormone Sales Value, 2019-2030
6.8.2 Southeast Asia Recombinant Human Parathyroid Hormone Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Recombinant Human Parathyroid Hormone Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Recombinant Human Parathyroid Hormone Sales Value, 2019-2030
6.9.2 India Recombinant Human Parathyroid Hormone Sales Value by Type (%), 2023 VS 2030
6.9.3 India Recombinant Human Parathyroid Hormone Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 NPS Pharma(Shire)
7.1.1 NPS Pharma(Shire) Company Information
7.1.2 NPS Pharma(Shire) Introduction and Business Overview
7.1.3 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Sales, Revenue and Gross Margin (2019-2024)
7.1.4 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Product Offerings
7.1.5 NPS Pharma(Shire) Recent Development
7.2 Takeda
7.2.1 Takeda Company Information
7.2.2 Takeda Introduction and Business Overview
7.2.3 Takeda Recombinant Human Parathyroid Hormone Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Takeda Recombinant Human Parathyroid Hormone Product Offerings
7.2.5 Takeda Recent Development
7.3 Shandong Buchang Pharmaceuticals
7.3.1 Shandong Buchang Pharmaceuticals Company Information
7.3.2 Shandong Buchang Pharmaceuticals Introduction and Business Overview
7.3.3 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Product Offerings
7.3.5 Shandong Buchang Pharmaceuticals Recent Development
7.4 Ascendis Pharma
7.4.1 Ascendis Pharma Company Information
7.4.2 Ascendis Pharma Introduction and Business Overview
7.4.3 Ascendis Pharma Recombinant Human Parathyroid Hormone Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Ascendis Pharma Recombinant Human Parathyroid Hormone Product Offerings
7.4.5 Ascendis Pharma Recent Development
7.5 Beijing SL Pharmaceutical
7.5.1 Beijing SL Pharmaceutical Company Information
7.5.2 Beijing SL Pharmaceutical Introduction and Business Overview
7.5.3 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Product Offerings
7.5.5 Beijing SL Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Recombinant Human Parathyroid Hormone Industrial Chain
8.2 Recombinant Human Parathyroid Hormone Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Recombinant Human Parathyroid Hormone Sales Model
8.5.2 Sales Channel
8.5.3 Recombinant Human Parathyroid Hormone Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
Takeda
Ascendis Pharma
Beijing SL Pharmaceutical
NPS Pharma(Shire)
Shandong Buchang Pharmaceuticals
List of Tables
    Table 1. Recombinant Human Parathyroid Hormone Market Trends
    Table 2. Recombinant Human Parathyroid Hormone Market Drivers & Opportunity
    Table 3. Recombinant Human Parathyroid Hormone Market Challenges
    Table 4. Recombinant Human Parathyroid Hormone Market Restraints
    Table 5. Global Recombinant Human Parathyroid Hormone Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Recombinant Human Parathyroid Hormone Revenue Market Share by Company (2019-2024)
    Table 7. Global Recombinant Human Parathyroid Hormone Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Recombinant Human Parathyroid Hormone Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Recombinant Human Parathyroid Hormone Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Recombinant Human Parathyroid Hormone Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Recombinant Human Parathyroid Hormone Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Recombinant Human Parathyroid Hormone
    Table 13. Global Recombinant Human Parathyroid Hormone Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Parathyroid Hormone as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Recombinant Human Parathyroid Hormone Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Recombinant Human Parathyroid Hormone Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Recombinant Human Parathyroid Hormone Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Recombinant Human Parathyroid Hormone Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Recombinant Human Parathyroid Hormone Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Recombinant Human Parathyroid Hormone Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Recombinant Human Parathyroid Hormone Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Recombinant Human Parathyroid Hormone Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Recombinant Human Parathyroid Hormone Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Recombinant Human Parathyroid Hormone Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Recombinant Human Parathyroid Hormone Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Recombinant Human Parathyroid Hormone Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Recombinant Human Parathyroid Hormone Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Recombinant Human Parathyroid Hormone Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Recombinant Human Parathyroid Hormone Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Recombinant Human Parathyroid Hormone Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Recombinant Human Parathyroid Hormone Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Recombinant Human Parathyroid Hormone Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Recombinant Human Parathyroid Hormone Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Recombinant Human Parathyroid Hormone Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Recombinant Human Parathyroid Hormone Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Recombinant Human Parathyroid Hormone Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Recombinant Human Parathyroid Hormone Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Recombinant Human Parathyroid Hormone Sales Value by Region (2019-2024) & (%)
    Table 44. Global Recombinant Human Parathyroid Hormone Sales Value by Region (2025-2030) & (%)
    Table 45. Global Recombinant Human Parathyroid Hormone Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Recombinant Human Parathyroid Hormone Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Recombinant Human Parathyroid Hormone Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Recombinant Human Parathyroid Hormone Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Recombinant Human Parathyroid Hormone Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Recombinant Human Parathyroid Hormone Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Recombinant Human Parathyroid Hormone Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Recombinant Human Parathyroid Hormone Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Recombinant Human Parathyroid Hormone Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Recombinant Human Parathyroid Hormone Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Recombinant Human Parathyroid Hormone Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Recombinant Human Parathyroid Hormone Sales Volume, (2025-2030) & (K Units)
    Table 57. NPS Pharma(Shire) Company Information
    Table 58. NPS Pharma(Shire) Introduction and Business Overview
    Table 59. NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Product Offerings
    Table 61. NPS Pharma(Shire) Recent Development
    Table 62. Takeda Company Information
    Table 63. Takeda Introduction and Business Overview
    Table 64. Takeda Recombinant Human Parathyroid Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Takeda Recombinant Human Parathyroid Hormone Product Offerings
    Table 66. Takeda Recent Development
    Table 67. Shandong Buchang Pharmaceuticals Company Information
    Table 68. Shandong Buchang Pharmaceuticals Introduction and Business Overview
    Table 69. Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Product Offerings
    Table 71. Shandong Buchang Pharmaceuticals Recent Development
    Table 72. Ascendis Pharma Company Information
    Table 73. Ascendis Pharma Introduction and Business Overview
    Table 74. Ascendis Pharma Recombinant Human Parathyroid Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Ascendis Pharma Recombinant Human Parathyroid Hormone Product Offerings
    Table 76. Ascendis Pharma Recent Development
    Table 77. Beijing SL Pharmaceutical Company Information
    Table 78. Beijing SL Pharmaceutical Introduction and Business Overview
    Table 79. Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Product Offerings
    Table 81. Beijing SL Pharmaceutical Recent Development
    Table 82. Key Raw Materials Lists
    Table 83. Raw Materials Key Suppliers Lists
    Table 84. Recombinant Human Parathyroid Hormone Downstream Customers
    Table 85. Recombinant Human Parathyroid Hormone Distributors List
    Table 86. Research Programs/Design for This Report
    Table 87. Key Data Information from Secondary Sources
    Table 88. Key Data Information from Primary Sources
List of Figures
    Figure 1. Recombinant Human Parathyroid Hormone Product Picture
    Figure 2. Global Recombinant Human Parathyroid Hormone Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Recombinant Human Parathyroid Hormone Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Recombinant Human Parathyroid Hormone Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Recombinant Human Parathyroid Hormone Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Recombinant Human Parathyroid Hormone Report Years Considered
    Figure 7. Global Recombinant Human Parathyroid Hormone Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Recombinant Human Parathyroid Hormone Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Recombinant Human Parathyroid Hormone Revenue in 2023
    Figure 10. Recombinant Human Parathyroid Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. 25 mcg/dose Picture
    Figure 12. 50 mcg/dose Picture
    Figure 13. 75 mcg/dose Picture
    Figure 14. 100 mcg/dose Picture
    Figure 15. Global Recombinant Human Parathyroid Hormone Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Recombinant Human Parathyroid Hormone Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Global Recombinant Human Parathyroid Hormone Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 18. Global Recombinant Human Parathyroid Hormone Sales Volume Market Share by Type, 2023 & 2030
    Figure 19. Global Recombinant Human Parathyroid Hormone Price by Type (2019-2030) & (US$/Unit)
    Figure 20. Product Picture of Postmenopausal Women with Osteoporosis
    Figure 21. Product Picture of Hypocalcemia in Patients with Hypoparathyroidism
    Figure 22. Global Recombinant Human Parathyroid Hormone Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Recombinant Human Parathyroid Hormone Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Recombinant Human Parathyroid Hormone Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 25. Global Recombinant Human Parathyroid Hormone Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Recombinant Human Parathyroid Hormone Price by Application (2019-2030) & (US$/Unit)
    Figure 27. North America Recombinant Human Parathyroid Hormone Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Recombinant Human Parathyroid Hormone Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Recombinant Human Parathyroid Hormone Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Recombinant Human Parathyroid Hormone Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Recombinant Human Parathyroid Hormone Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Recombinant Human Parathyroid Hormone Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Recombinant Human Parathyroid Hormone Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Recombinant Human Parathyroid Hormone Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Recombinant Human Parathyroid Hormone Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Recombinant Human Parathyroid Hormone Sales Volume (%), (2019-2030)
    Figure 39. United States Recombinant Human Parathyroid Hormone Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Recombinant Human Parathyroid Hormone Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Recombinant Human Parathyroid Hormone Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Recombinant Human Parathyroid Hormone Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Recombinant Human Parathyroid Hormone Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Recombinant Human Parathyroid Hormone Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Recombinant Human Parathyroid Hormone Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Recombinant Human Parathyroid Hormone Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Recombinant Human Parathyroid Hormone Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Recombinant Human Parathyroid Hormone Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Recombinant Human Parathyroid Hormone Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Recombinant Human Parathyroid Hormone Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Recombinant Human Parathyroid Hormone Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Recombinant Human Parathyroid Hormone Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Recombinant Human Parathyroid Hormone Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Recombinant Human Parathyroid Hormone Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Recombinant Human Parathyroid Hormone Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Recombinant Human Parathyroid Hormone Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Recombinant Human Parathyroid Hormone Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Recombinant Human Parathyroid Hormone Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Recombinant Human Parathyroid Hormone Sales Value by Application (%), 2023 VS 2030
    Figure 60. Recombinant Human Parathyroid Hormone Industrial Chain
    Figure 61. Recombinant Human Parathyroid Hormone Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions